Literature DB >> 31451247

Nutritional support in cirrhotic patients with sarcopenia.

João Vasques1, Catarina Sousa Guerreiro2, Joana Sousa3, Mariana Pinto4, Helena Cortez-Pinto5.   

Abstract

Sarcopenia has been linked to oncologic and chronic diseases such as liver cirrhosis. In fact, sarcopenia is present in 25-70% of patients with liver cirrhosis. Furthermore, sarcopenia is an independent predictor of poor prognosis in many diseases. Currently cirrhotic patients are recommended to adopt a high protein diet (1.5 g/kg/day) with 30-40 kcal/kg/day and several meals throughout the day, being late evening snack intake with at least 50 g of carbohydrates of special importance. Despite the growing interest in the impact of sarcopenia in cirrhotic patients, there are still gaps in knowledge in the appropriate diagnostic criteria for this syndrome, the role of gut microbiota, as well as the most appropriate nutritional therapy.
Copyright © 2019 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Liver cirrhosis; Nutritional support; Sarcopenia

Year:  2019        PMID: 31451247     DOI: 10.1016/j.clnesp.2019.07.011

Source DB:  PubMed          Journal:  Clin Nutr ESPEN        ISSN: 2405-4577


  3 in total

1.  Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy.

Authors:  Silvia Espina; Yolanda Gonzalez-Irazabal; Alejandro Sanz-Paris; Marta Lopez-Yus; Maria Pilar Garcia-Sobreviela; Raquel Del Moral-Bergos; Beatriz Garcia-Rodriguez; Javier Fuentes-Olmo; Vanesa Bernal-Monterde; Jose M Arbones-Mainar
Journal:  Nutrients       Date:  2021-10-25       Impact factor: 5.717

2.  Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis.

Authors:  Koji Murata; Kosuke Kaji; Norihisa Nishimura; Masahide Enomoto; Yuki Fujimoto; Soichi Takeda; Yuki Tsuji; Yukihisa Fujinaga; Hiroaki Takaya; Hideto Kawaratani; Tadashi Namisaki; Takemi Akahane; Hitoshi Yoshiji
Journal:  Int J Mol Med       Date:  2022-06-10       Impact factor: 5.314

3.  Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China.

Authors:  Xin Zeng; Zhi-Wen Shi; Jia-Jun Yu; Li-Fen Wang; Yuan-Yuan Luo; Si-Min Jin; Li-Yuan Zhang; Wei Tan; Pei-Mei Shi; Hong Yu; Chun-Qing Zhang; Wei-Fen Xie
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-09-14       Impact factor: 12.910

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.